rs150546646
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_152468.5(TMC8):c.1168G>A(p.Val390Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000941 in 1,613,930 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_152468.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMC8 | NM_152468.5 | c.1168G>A | p.Val390Ile | missense_variant | 10/16 | ENST00000318430.10 | NP_689681.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMC8 | ENST00000318430.10 | c.1168G>A | p.Val390Ile | missense_variant | 10/16 | 1 | NM_152468.5 | ENSP00000325561 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000822 AC: 125AN: 152142Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00103 AC: 258AN: 251114Hom.: 1 AF XY: 0.00105 AC XY: 142AN XY: 135858
GnomAD4 exome AF: 0.000952 AC: 1391AN: 1461670Hom.: 5 Cov.: 31 AF XY: 0.000972 AC XY: 707AN XY: 727108
GnomAD4 genome AF: 0.000834 AC: 127AN: 152260Hom.: 1 Cov.: 33 AF XY: 0.000940 AC XY: 70AN XY: 74446
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Epidermodysplasia verruciformis, susceptibility to, 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | TMC8 NM_152468.4 exon 10 p.Val390Ile (c.1168G>A): This variant has not been reported in the literature but is present in 0.1% (47/35426) of Latino alleles, including 1 homozygote in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/17-76133356-G-A?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:456021). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Epidermodysplasia verruciformis, susceptibility to, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Apr 17, 2020 | TMC8 NM_152468.4 exon 10 p.Val390Ile (c.1168G>A): This variant has not been reported in the literature but is present in 0.1% (47/35426) of Latino alleles, including 1 homozygote in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/17-76133356-G-A?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:456021). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
TMC8-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 01, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Epidermodysplasia verruciformis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at